고정된 트윗
FYI for those that don't know.. to help you from those who do😉
I did this just to try to level the playing field
English
Brass Bull Alerts
13K posts
Brass Bull Alerts
@MicroCapTweets
Experienced trader/consultant. Alert trade ideas, insight & client cos info. ALL OUR OPINION. Don't take stock! https://t.co/REI24v9xdI
Anywhere 가입일 Aralık 2013
117 팔로잉3.5K 팔로워
$MAJI looking for a great week here.. bring on those definitive agreements and let's hear some rumblings from $LMMY 😁
@NexTelMedical @ExousiaBio
TIGRESS🐯@og_tigress
$MAJI completed an exclusive licensing agreement recently with the University of Central Florida for it's cancer diagnostic and therapy platforms of it's wholly owned subsidiary Exousia Pro Holding Management. This grants UCF to develop patented and patent-pending intellectual technology which includes the Exosomal NANOG DNA as a Diagnotic Cancer Marker and the Exosomal Delivery Platform for Therapy. It will ensure moving forward they maintain a dominant position over foundational technologies essential for developing next-generation exosome-based diagnostics and therapeutics. The DNA cancer screening test is a non-invasive diagnostic tool which will be able to test a wide range of cancers earlier through saliva. otcmarkets.com/stock/MAJI/new…
English
Brass Bull Alerts 리트윗함
$MAJI completed an exclusive licensing agreement recently with the University of Central Florida for it's cancer diagnostic and therapy platforms of it's wholly owned subsidiary Exousia Pro Holding Management.
This grants UCF to develop patented and patent-pending intellectual technology which includes the Exosomal NANOG DNA as a Diagnotic Cancer Marker and the Exosomal Delivery Platform for Therapy. It will ensure moving forward they maintain a dominant position over foundational technologies essential for developing next-generation exosome-based diagnostics and therapeutics.
The DNA cancer screening test is a non-invasive diagnostic tool which will be able to test a wide range of cancers earlier through saliva.
otcmarkets.com/stock/MAJI/new…
TIGRESS🐯@og_tigress
$MAJI in October the company was awareded Orphan Drug Designation for its exosome-based GBM treatment also known as Glioblastoma multiforme. Only 11% of orphan drug designations are awarded at the preclinical stage. "Our breakthrough exosomal technology has the ability to deliver a wide range of therapeutics, including genetic material, into cells afflicted with cancer, such as GBM. The therapeutic technology presented in this orphan drug application is a method for using exosomes loaded with desired nucleic acids, in the effective treatment of GBM when combined with currently available standard anticancer therapy." They plan to work with investment bankers to expand and monetize the therapy. A product like this could bring in 10's of millions of dollars alone to the company. otcmarkets.com/stock/MAJI/new…
English
Brass Bull Alerts 리트윗함
@MicroCapTweets I believe at current market prices it’s $18.3mill in market cap for $MAJI an 11x from here!!
$LMMY $.489
English
$MAJI nice bid! Bids building, next week should be exciting with several developments coming to fruition and $LMMY should start updating shareholders on progress from the Orphan Drug side 😀
Dont forget $MAJI owns about $12mm of $LMMY at today's prices , not bad when our market cap is <$2mm
English
Brass Bull Alerts 리트윗함
@og_tigress Not to mention that using exisomes with Mercks cancer drug greatly improved the efficacy of Mercks drug from roughly 25% effective to almost 100% effective in killing brain cancer stem cells!!
Wonder how valuable that is to Merck?? Amazing opportunity here!
$MAJI
$LMMY
English
Brass Bull Alerts 리트윗함
$MAJI in October the company was awareded Orphan Drug Designation for its exosome-based GBM treatment also known as Glioblastoma multiforme. Only 11% of orphan drug designations are awarded at the preclinical stage.
"Our breakthrough exosomal technology has the ability to deliver a wide range of therapeutics, including genetic material, into cells afflicted with cancer, such as GBM. The therapeutic technology presented in this orphan drug application is a method for using exosomes loaded with desired nucleic acids, in the effective treatment of GBM when combined with currently available standard anticancer therapy."
They plan to work with investment bankers to expand and monetize the therapy. A product like this could bring in 10's of millions of dollars alone to the company.
otcmarkets.com/stock/MAJI/new…
TIGRESS🐯@og_tigress
$MAJI currently owns a controlling stake in $LMMY which is a SEC-reporting stock trading at $0.49 per share - 10X MAJI current PPS. With the strategic alignment of the two entities, MAJI owns 51% of their restricted stock making them the controlling shareholder. Per their November 2025 PR this will be used to raise capital and ensure the funding is non-dilutive to MAJI shareholders. LMMY intends to begin the process to uplist to Nasdaq. otcmarkets.com/stock/MAJI/new…
English
$MAJI 100% ... company and Matt have been doubted, ignored and bashed by most of #OTC (for whatever reason.. hmm 🤔)
But they are delivering and the best is still yet to come (wait til $LMMY starts dropping news ).. just remember who has seen it and pounded the table .. and who hasn't 😉
Investing 4 Life@StockBullPicks
@MicroCapTweets @SuperRobotGX $MAJI Amazing - everything they are announcing isn’t reflected in the stock price They are: > making acquisitions > tightening and protecting the share structure > rolling out patent protected new products > expanding into different sectors with same technology (Derm and CBD)
English
$MAJI this alone as it rolls out is worth 10x +++ from current market levels ... so much happening very quickly
NextTel Medical Corp@NexTelMedical
Exciting news for $MAJI: When our site is live! Anyone interested in joining our groundbreaking cancer screening study can now sign up directly online. Once enrolled, you’ll receive a comprehensive at-home collection kit with clear instructions for a seamless return. Your results will be delivered securely via email, and all data is strictly managed under HIPAA guidelines to ensure your privacy. Join us in advancing early detection!..more to come.
English
Brass Bull Alerts 리트윗함
$SETO this another one to not sleep on... they are building out a portfolio and distribution platform that already has their brands in Total Wine...
Being ignored because the volume has not been there... but it will and we know what happens when vol shows up
SETO Holdings@Setoholdingsinc
English
$MAJI
Chart/stock is shaping up nicely.. showing strong short-term momentum after bottoming in early March. It has surged ~31% over the past week and ~25-30% over the past month, climbing from the March low near $0.015–$0.021 to higher highs ($0.0216 → $0.0285 → $0.0332 → $0.0370 → $0.0420 → $0.0440 → $0.0462).
Key bullish technical developments:
Price has decisively broken and held above its 20-day EMA (~$0.0334) and is now trading above the 50-day EMA (~$0.0434), indicating a potential trend reversal and short-term uptrend confirmation.
Volume has grown over the recent moves (i.e. 237k shares on the March 23 breakout day and 163k on March 25), showing true buyer conviction rather than low-volume pops.
This setup—sharp recovery off the lows, higher-highs/higher-lows and moving-average reclaims—supports potential continued upside in the near term. Next key levels are the $0.05–$0.06 range (recent highs), with further potential toward $0.08–$0.10 if momentum holds. The chart is technically strong and positioned for a move higher as long as it holds above the rising short-term support (~$0.03)
English
Brass Bull Alerts 리트윗함
$MAJI These revs are adding up! Hope everyone is keeping track
NextTel Medical Corp@NexTelMedical
$MAJI — the telehealth company with which we are finalizing a definitive agreement — is currently renegotiating terms with 1,900 clinics to expand its role as sole distributor beyond testosterone. The existing testosterone program alone generates approximately $4 per script across an estimated 2,000 daily prescriptions, highlighting meaningful revenue potential with significant upside as the partnership broadens. #OTC
English
Brass Bull Alerts 리트윗함
$MAJI 10x+ potential if @NexTelMedical keeps on delivering
TIGRESS🐯@og_tigress
$MAJI currently owns a controlling stake in $LMMY which is a SEC-reporting stock trading at $0.49 per share - 10X MAJI current PPS. With the strategic alignment of the two entities, MAJI owns 51% of their restricted stock making them the controlling shareholder. Per their November 2025 PR this will be used to raise capital and ensure the funding is non-dilutive to MAJI shareholders. LMMY intends to begin the process to uplist to Nasdaq. otcmarkets.com/stock/MAJI/new…
English
Brass Bull Alerts 리트윗함
$MAJI is they sign those DA for the LOI's and those deals worth $100m as stated in their corporate update, this thing is going to go bananas - $PLTR $VXIT Boom! @thommic @cdntradegrljenn
TIGRESS🐯@og_tigress
$MAJI on top of the most recent update, the company released a roadmap late February where it went into detail not only the share cancellations but ongoing strategic developments in the works, with more to be added come April. Still pending is closing of definitive agreements to acquire 3 telehealth previously under LOI, closing an anticipated $100M deal as well as the launch of a new website. globenewswire.com/news-release/2…
English
Brass Bull Alerts 리트윗함
$MAJI Super stoked for this one, once PR’s start dropping probably never see these prices again, gett’em while you can!
Investing 4 Life@StockBullPicks
$MAJI owns 51% of $LMMY ARB UPDATE after the recent OS reduction for MAJI OS: MAJI=37,750,959 LMMY=73,500,000 Current prices: MAJI= .042 LMMY= .489 Arb value diff for $MAJI .042 to .486 (11.5x diff) Currently 1:1 for stock price value w/ $LMMY Worth 11.5 times current price!
English
Brass Bull Alerts 리트윗함
$MAJI on top of the most recent update, the company released a roadmap late February where it went into detail not only the share cancellations but ongoing strategic developments in the works, with more to be added come April.
Still pending is closing of definitive agreements to acquire 3 telehealth previously under LOI, closing an anticipated $100M deal as well as the launch of a new website.
globenewswire.com/news-release/2…
TIGRESS🐯@og_tigress
$MAJI worth keeping an eye on with recent news which started the chart reversal earlier last week and expected to close within 30 days from March 16th. Maji will make a one time payment of $147.5K which will allow the company to secure favorable financial restructuring outcomes. 🔥$200K promissory note cancellation 🔥Eliminate remaining balance tied to control block of preferred shares 🔥Nearly 6.3M shares of common stock cancelled and returned to treasury 🔥Allow the company to proceed with a clean, streamlined audit "By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation." otcmarkets.com/stock/MAJI/new…
English
Brass Bull Alerts 리트윗함
Brass Bull Alerts 리트윗함
$MAJI READY TO MAKE SOME NOISE SOON 🧐
x.com/i/status/20361…
NextTel Medical Corp@NexTelMedical
Big news for $MAJI shareholders: We are nearing the execution of our first Definitive Agreement, covering two of our Telehealth acquisitions! To mark the occasion, we’re hosting a special session with @buffalofireside featuring the founder from these companies. This is a rare opportunity to hear directly from the visionary behind these two acquisitions, as well as about our integration strategy and the future of our telehealth ecosystem. Stay tuned for the official announcement—you won't want to miss this DD!...more to come.
English
$MAJI $LMMY letsss goooo!!
So looking forward to this... things are evolving very quickly, here is where expinential growth starts to show up
NextTel Medical Corp@NexTelMedical
Big news for $MAJI shareholders: We are nearing the execution of our first Definitive Agreement, covering two of our Telehealth acquisitions! To mark the occasion, we’re hosting a special session with @buffalofireside featuring the founder from these companies. This is a rare opportunity to hear directly from the visionary behind these two acquisitions, as well as about our integration strategy and the future of our telehealth ecosystem. Stay tuned for the official announcement—you won't want to miss this DD!...more to come.
English